Drugs in development for toxoplasmosis: advances, challenges, and current status
P Holland Alday,1 Joseph Stone Doggett1,2 1Division of Infectious Diseases, Oregon Health & Science University, 2Portland Veterans Affairs Medical Center, Portland, OR, USA Abstract: Toxoplasma gondii causes fatal and debilitating brain and eye diseases. Medicines that are currently used t...
Main Authors: | Alday PH, Doggett JS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-01-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/drugs-in-development-for-toxoplasmosis-advances-challenges-and-current-peer-reviewed-article-DDDT |
Similar Items
-
Essential function of the alveolin network in the subpellicular microtubules and conoid assembly in Toxoplasma gondii
by: Nicolò Tosetti, et al.
Published: (2020-05-01) -
Toxoplasma gondii in experimentally infected Bos taurus and Bos indicus semen and tissues Toxoplasma gondii em semen e tecidos de Bos taurus and Bos indicus experimentalmente infectados
by: Leslie Scarpelli, et al.
Published: (2009-01-01) -
Caracterisation moléculaire et fonctionnelle de la jonction mobile contrôlant l'invasion de la cellule hôte par Toxoplasma gondii
by: Roques, Magali
Published: (2012) -
Etude de la synthèse des précurseurs majeurs à la synthèse des lipides membraniares : l'acide lysophosphatidique et l'acide phosphatidique chez Toxoplasma gondii
by: Amiar, Souad
Published: (2016) -
Screening for Toxoplasma gondii in aborted bovine fetuses in Brazil
by: A.D. Cabral, et al.